Strategies for Hepatitis B Virus Prevention in People Living with HIV
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies for Hepatitis B Virus Prevention in People Living with HIV
Authors
Keywords
-
Journal
Current HIV/AIDS Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-14
DOI
10.1007/s11904-023-00670-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunogenicity and Safety of Hepatitis B Vaccine With a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People With Human Immunodeficiency Virus (HIV)
- (2023) Kristen M Marks et al. CLINICAL INFECTIOUS DISEASES
- Observational Study Evaluating the Seroprotection of HepB-alum Vaccine and HepB-CpG Vaccine in People with HIV
- (2023) Brenna Reilly-Evans et al. Open Forum Infectious Diseases
- Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose
- (2022) Michael G. Bruce et al. HEPATOLOGY
- Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
- (2022) Mark K. Weng et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- 1583. A Case Series of Low-Level HBV Viremia After Switching to Long-Acting Injectable Cabotegravir/Rilpivirine in Patients with HIV, Hepatitis B Core Antibody Positivity, and Hepatitis B Surface Antigen Negativity
- (2022) Elliott Welford et al. Open Forum Infectious Diseases
- Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda
- (2021) E. Seremba et al. VACCINE
- Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
- (2021) Timo Vesikari et al. LANCET INFECTIOUS DISEASES
- Serological response with Heplisav-B® in prior Hepatitis B vaccine non-responders living with HIV
- (2021) Rebecca Khaimova et al. VACCINE
- Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis
- (2021) Yakun Tian et al. Frontiers in Immunology
- Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine
- (2021) Timo Vesikari et al. JAMA Network Open
- Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients
- (2020) Jung-Hwan Lee et al. VACCINE
- Acute Hepatitis B Infection After a Switch to Long-Acting Cabotegravir and Rilpivirine
- (2020) Claire Pintado et al. Open Forum Infectious Diseases
- Brief Report: Heplisav-B Seroprotection in People With HIV: A Single-Center Experience
- (2020) Samuel R. Schnittman et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV
- (2019) Jennifer L Grant et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV
- (2019) Priya D. Farooq et al. Current HIV/AIDS Reports
- Global Burden of Hepatitis B Infection in People Living With Human Immunodeficiency Virus: A Systematic Review and Meta-analysis
- (2019) Steve Leumi et al. CLINICAL INFECTIOUS DISEASES
- Prevalence and burden of HBV co‐infection among people living with HIV: A global systematic review and meta‐analysis
- (2019) Lucy Platt et al. JOURNAL OF VIRAL HEPATITIS
- HBV vaccination in HIV: immunogenicity and persistence of seroprotection up to 7 years following a primary immunization course
- (2018) laura ambra nicolini et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study
- (2017) Giulia Morsica et al. PLoS One
- Vaccination Against Hepatitis B Virus (HBV) in HIV-1–Infected Patients With Isolated Anti–HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study
- (2016) Lionel Piroth et al. JOURNAL OF INFECTIOUS DISEASES
- Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis
- (2016) Mohaned Shilaih et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose
- (2016) Michael G. Bruce et al. JOURNAL OF INFECTIOUS DISEASES
- Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
- (2016) Calvin Q. Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods
- (2015) Oluwaseun Falade-Nwulia et al. ANNALS OF INTERNAL MEDICINE
- Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis
- (2015) Robert S. Brown et al. HEPATOLOGY
- Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection
- (2014) Merel M. Heuft et al. AIDS
- Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection
- (2013) Hiroyuki Gatanaga et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age
- (2013) William L. Heyward et al. VACCINE
- Comparative Risk of Liver-Related Mortality From Chronic Hepatitis B Versus Chronic Hepatitis C Virus Infection
- (2012) O. Falade-Nwulia et al. CLINICAL INFECTIOUS DISEASES
- Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen
- (2012) Chloe Kaech et al. JOURNAL OF INFECTION
- Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults
- (2012) D.V. Potsch et al. VACCINE
- Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age
- (2012) Scott A. Halperin et al. VACCINE
- Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007†
- (2010) P. R. Spradling et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations
- (2009) H N Kim et al. INTERNATIONAL JOURNAL OF STD & AIDS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started